Success Metrics

Clinical Success Rate

100.0%

Based on 2 completed trials

Completion Rate

100%(2/2)

Active Trials

3(38%)

Results Posted

50%(1 trials)

Phase Distribution

Ph phase_3

13%

Ph phase_4

63%

Ph not_applicable

13%

Ph phase_2

13%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution8 total trials

Phase 2Efficacy & side effects

1(12.5%)

Phase 3Large-scale testing

1(12.5%)

Phase 4Post-market surveillance

5(62.5%)

N/ANon-phased studies

1(12.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(4)

Completed(2)

Other(2)

Detailed Status

Recruiting3

Completed2

unknown2

Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 4

Trials by Phase

Phase 21 (12.5%)

Phase 31 (12.5%)

Phase 45 (62.5%)

N/A1 (12.5%)

Trials by Status

completed225%

not_yet_recruiting113%

recruiting338%

unknown225%

Recent Activity

3 active trials

Showing 5 of 8

recruitingphase_4

Refining Treatment Options for Trichomonas Vaginalis Infection: A Comparative Analysis of Metronidazole and Secnidazole

NCT06261840

not_yet_recruitingphase_2

Chlorhexidine and/or Metronidazole Plus FB301 Pre-treatment Trial

NCT07481955

recruitingphase_4

Improvement of PPROM Management With Prophylactic Antimicrobial Therapy (iPROMPT)

NCT06396078

completedphase_4

Helicobacter Pylori Eradication Study

NCT03130452

recruitingphase_4

Optimization of Bacterial Vaginosis Treatment in Women of Reproductive Age

NCT06458543

View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials

NCT06261840Phase 4

Refining Treatment Options for Trichomonas Vaginalis Infection: A Comparative Analysis of Metronidazole and Secnidazole

Recruiting

NCT07481955Phase 2

Chlorhexidine and/or Metronidazole Plus FB301 Pre-treatment Trial

Not Yet Recruiting

NCT06396078Phase 4

Improvement of PPROM Management With Prophylactic Antimicrobial Therapy (iPROMPT)

Recruiting

NCT03130452Phase 4

Helicobacter Pylori Eradication Study

Completed

NCT06458543Phase 4

Optimization of Bacterial Vaginosis Treatment in Women of Reproductive Age

Recruiting

NCT05385887Not Applicable

Antibiotic Treatment foLlowing Surgical drAinage of Perianal abScess; the ATLAS Trial

Unknown

NCT04090021Phase 4

Genotypic Resistance-guided Versus Empirical Therapy for H. Pylori Eradication.

Unknown

NCT02739997Phase 3

Study of Ceftolozane/Tazobactam (MK-7625A) in Combination With Metronidazole in Japanese Participants With Complicated Intra-abdominal Infection (MK-7625A-013)

Completed

All 8 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 8